ArticleMedicine2026
Relapsed/refractory PBML complicated with failed platelet implantation and mixed infection after allo-HSCT: A case report.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
rationalePrimary bone marrow lymphoma (PBML) is a rare lymphoma with a poor prognosis, characterized by tumor origin restricted to the bone marrow. Diffuse large B-cell lymphoma (DLBCL) is its most common subtype. PATIENT CONCERNS: We report a case of a 48-year-old female with refractory non-germinal center DLBCL originating in the bone marrow, accompanied by p53 overexpression, complex karyotype, and hemophagocytic lymphohistiocytosis. DIAGNOSES: Given the aforementioned adverse genetic features, together with primary platelet poor graft function following allogeneic hematopoietic stem cell transplantation (allo-HSCT), mixed infections, severe acute intestinal graft-versus-host disease (GVHD), and progressive bone marrow stromal necrosis, the patient was diagnosed with multifactorial post-transplant poor graft function with bone marrow microenvironment injury.
interventionsThe patient received induction chemotherapy and achieved complete remission, followed by autologous-hematopoietic stem cell transplantation (autoHSCT) for consolidation. After relapse within 3 months, salvage therapy and subsequent allogeneic-hematopoietic stem cell transplantation were performed. OUTCOMES: Despite intensive supportive therapy, the patient died from massive gastrointestinal bleeding. A literature review identified this as a rare case of PBML with primary platelet Poor graft function and mixed infections post-allo-HSCT. LESSONS: This case highlights the treatment challenges and extremely poor prognosis in ultrahigh-risk PBML with adverse genetic features and severe post-transplant complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.